| GeNoCiDe vs King | 38–25 | 60.32% |
| GeNoCiDe vs Jin | 30–26 | 53.57% |
| GeNoCiDe vs Heihachi | 21–26 | 44.68% |
| GeNoCiDe vs Bryan | 23–23 | 50.00% |
| GeNoCiDe vs Reina | 23–23 | 50.00% |
| GeNoCiDe vs Kazuya | 25–19 | 56.82% |
| GeNoCiDe vs Steve | 23–15 | 60.53% |
| GeNoCiDe vs Hwoarang | 16–18 | 47.06% |
| GeNoCiDe vs Lili | 8–25 | 24.24% |
| GeNoCiDe vs Azucena | 17–14 | 54.84% |
| GeNoCiDe vs Lee | 15–15 | 50.00% |
| GeNoCiDe vs Lars | 14–13 | 51.85% |
| GeNoCiDe vs Yoshimitsu | 7–16 | 30.43% |
| GeNoCiDe vs Eddy | 14–8 | 63.64% |
| GeNoCiDe vs Dragunov | 12–6 | 66.67% |
| GeNoCiDe vs Law | 7–10 | 41.18% |
| GeNoCiDe vs Xiaoyu | 9–8 | 52.94% |
| GeNoCiDe vs Devil Jin | 6–9 | 40.00% |
| GeNoCiDe vs Leo | 3–11 | 21.43% |
| GeNoCiDe vs Jun | 10–4 | 71.43% |
| GeNoCiDe vs Feng | 3–10 | 23.08% |
| GeNoCiDe vs Leroy | 7–6 | 53.85% |
| GeNoCiDe vs Paul | 6–6 | 50.00% |
| GeNoCiDe vs Asuka | 4–8 | 33.33% |
| GeNoCiDe vs Nina | 4–8 | 33.33% |
| GeNoCiDe vs Lidia | 5–6 | 45.45% |
| GeNoCiDe vs Alisa | 4–6 | 40.00% |
| GeNoCiDe vs Victor | 2–8 | 20.00% |
| GeNoCiDe vs Kuma | 1–7 | 12.50% |
| GeNoCiDe vs Claudio | 2–4 | 33.33% |
| GeNoCiDe vs Clive | 3–3 | 50.00% |
| GeNoCiDe vs Jack-8 | 2–3 | 40.00% |
| GeNoCiDe vs Shaheen | 0–2 | 0.00% |
| GeNoCiDe vs Panda | 0–2 | 0.00% |
| GeNoCiDe vs Anna | 0–2 | 0.00% |
| GeNoCiDe vs Zafina | 0–1 | 0.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.